Literature DB >> 12203151

[Scapholunate dissociation: treatment by dorsal capsulodesis].

F Busse1, J Felderhoff, H Krimmer, U Lanz.   

Abstract

Between December 1994 and December 1996, 26 patients with a scapholunate ligament injury (three with SLD 1. degrees, 16 with SLD 2. degrees and 7 with SLD 3. degrees ) underwent an operation for dorsal capsulodesis in the Klinik für Handchirurgie, Bad Neustadt/Saale. Mean follow-up was 24 months (16 to 37 months). Follow-up criteria were range of motion, grip strength, pain relief, and X-ray findings. Clinical outcome was evaluated using a personal questionnaire, the DASH- and a modified Cooney-Score. Although significant reduction of joint mobility compared to the opposite site was found in all cases (E/F 32 %, U/R 19 %), the reduction of pain was 30 %. Grip-strength was not altered. Thus, 86 % of the patients were satisfied with the result obtained. On X-ray, the scapholunate angle was raised in the SLD 3. degrees -group by 12 degrees postoperatively; in the group with dynamic instability, X-ray findings were normal. Overall, 19 % (5/26) needed further operations due to persistent pain.

Entities:  

Mesh:

Year:  2002        PMID: 12203151     DOI: 10.1055/s-2002-33690

Source DB:  PubMed          Journal:  Handchir Mikrochir Plast Chir        ISSN: 0722-1819            Impact factor:   1.018


  3 in total

1.  Arthroscopic dorsal capsulo-ligamentous repair in the treatment of chronic scapho-lunate ligament tears.

Authors:  Abhijeet L Wahegaonkar; Christophe L Mathoulin
Journal:  J Wrist Surg       Date:  2013-05

2.  [Frequency of acute and chronic scapholunate dissociation in distal radius fractures. Different treatment plans].

Authors:  W Schneiders; M Amlang; S Rammelt; H Zwipp
Journal:  Unfallchirurg       Date:  2005-09       Impact factor: 1.000

3.  [Dorsal capsulodesis for the treatment of scapholunate instability].

Authors:  Christine Stephan; Karl-Josef Prommersberger; Jörg van Schoonhoven
Journal:  Oper Orthop Traumatol       Date:  2009-11       Impact factor: 1.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.